logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
K

Kan Yonemori

National Cancer Center Hospital

48H指数
1.0K论文数
1.1W被引数
收录论文 221
发表时间
logo
Efficacy and biomarker analysis for nivolumab in cancer of unknown primary: results from an investigator-initiated expanded access program纳武利尤单抗治疗未知原发灶癌症的疗效与生物标志物分析：来自研究者发起的扩展性准入项目的结果
errInternational Journal of Clinical Oncology
IF2.8
err2026-09-24
err0
errOAAI
errJunko Tanizaki; Kan Yonemori; Yuichi Takiguchi; Kohei Akiyoshi; Keigo Komine; Yusuke Onozawa; Mariko Sato; Kenro Hirata; Takuma Onoe; Ryotaro Ohkuma; Yosuke Horita; Hironobu Minami; Kazunori Honda; Koichi Suyama; Akihiko Ito; Yasutaka Chiba; Hiroko Watanabe; Yosuke Togashi; Kazuko Sakai; Kazuto Nishio; Kazuhiko Nakagawa; Hidetoshi Hayashi
err分享
err收藏
Synchronized CD73 blockade and STING activation via an ultrahigh-payload antibody-polymer conjugate for breast cancer immunotherapy通过超高载药抗体-聚合物偶联物同步阻断CD73和激活STING用于乳腺癌免疫治疗
errJournal of Nanobiotechnology
IF12.6
err2026-09-15
err0
errOAAI
errNaimeng Liu; Xiangyu Wang; Wenxiang Zhang; Juan Wu; Kan Yonemori; Baranova Madina Petrovna; Li Chen; Guofeng Ji; Zhongzhao Wang; Xiangyi Kong; Jing Wang
err分享
err收藏
Central nervous system symptom burden and clinical implications for antiemetic management with olanzapine in AC chemotherapy中枢神经系统症状负担及奥氮平在AC化疗中抗恶心管理的临床意义
errOncologist
IF4.2
err2026-09-09
err0
errOAAI
errRyoko Udagawa; Mototsugu Shimokawa; Hirotoshi Iihara; Rie Ozeki; Michiko Tsuneizumi; Manabu Futamura; Tomoyuki Fujita; Hideaki Ogata; Hiroko Bando; Toshitaka Uomori; Hironobu Hashimoto; Ryosuke Hayami; Yoshihisa Tokumaru; Goro Kutomi; Kan Yonemori; Ryoichi Matsunuma; Mika Kitahora; Naotake Yanagisawa; Tatsunori Shimoi; Mitsue Saito; null
err分享
err收藏
Safety and Efficacy of Vinorelbine and Continuous Low-Dose Cyclophosphamide Chemotherapy in Japanese Pediatric Patients With Relapsed or Refractory Rhabdomyosarcoma长春瑞滨和持续低剂量环磷酰胺化疗在日本复发性或难治性横纹肌肉瘤儿童患者中的安全性与有效性
errPEDIATRIC BLOOD & CANCER
IF2.3
err2026-07-01
err0
PREAI
errYanai, Risa; Sugiyama, Minako; Miyazaki, Bunpei; Kikuchi, Natsumi; Tamefusa, Kosuke; Tao, Kayoko; Uchida, Eriko; Isobe, Kiyotaka; Yonemori, Kan; Arakawa, Ayumu
err分享
err收藏
JAVEMACS: a real-world study of avelumab maintenance therapy for advanced urothelial carcinoma in JapanJAVEMACS：一项在日本进行的avelumab维持治疗晚期尿路上皮癌的真实世界研究
errESMO Real World Data and Digital Oncology
IF0
err2025-12-01
err0
errOAAI
errKitamura, H.; Kobayashi, T.; Endo, Y.; Ikeda, M.; Yonemori, K.; Nakayama, M.; Fujihara, A.; Abe, T.; Shimizu, F.; Fujimoto, K.; Nakagawa, T.; Hatakeyama, S.; Murakami, K.; Nishihara, K.; Ikarashi, D.; Masumori, N.; Naito, S.; Fujita, K.; Hayakawa, N.; Hara, T.; Miura, N.; Negishi, T.; Yatsuda, J.; Kobayashi, M.; Nishiyama, N.; Taoka, R.; Furukawa, J.; Shono, M.; Shirotake, S.; Kikuchi, E.
err分享
err收藏
Clinical, immunological, and genomic findings of atezolizumab in advanced alveolar soft part sarcoma: A phase II trial (ALBERT trial/NCCH1907)阿特朱单抗在晚期肺泡软组织肉瘤中的临床、免疫学及基因组学发现：一项II期试验（ALBERT试验/NCCH1907）
errEuropean Journal of Cancer
IF7.1
err2025-11-11
err0
PREAI
errYuki Kojima; Keisuke Watanabe; Motoko Arakaki; Tadaaki Nishikawa; Yukari Hoshina; Kenta Anjo; Akihiro Hirakawa; Masahiko Ichimura; Makoto Endo; Ikuo Kudawara; Masanobu Takahashi; Genki Okumura; Shohei Koyama; Akihiko Yoshida; Kouya Shiraishi; Hitoshi Ichikawa; Kan Yonemori
err分享
err收藏
RESULTS OF A MULTICENTER PHASE 2 BASKET TRIAL EVALUATING THE EFFICACY OF TASURGRATINIB (E7090) IN PATIENTS WITH ADVANCED SOLID TUMORS WITH FIBROBLAST GROWTH FACTOR RECEPTOR (FGFR) GENE ALTERATION, INCLUDING THOSE WITH PRIMARY BRAIN TUMORS: FORTUNE STUDY评估TASURGRATINIB（E7090）在具有成纤维细胞生长因子受体（FGFR）基因变异的晚期实体瘤患者（包括原发性脑肿瘤患者）中的疗效的多中心II期篮式试验结果：FORTUNE研究
errNEURO-ONCOLOGY
IF13.4
err2025-11-01
err0
errOAAI
errTakahashi, Masamichi; Sudo, Kazuki; Matsubara, Junichi; Tsuchihashi, Kenji; Kinoshita, Ichiro; Takahashi, Masanobu; Chiba, Yohei; Kohsaka, Shinji; Sadachi, Ryo; Machida, Ryunosuke; Ichimura, Masahiko; Okuma, Hitomi Sumiyoshi; Anjo, Kenta; Kurishita, Kazumi; Nakamura, Kenichi; Yonemori, Kan
err分享
err收藏
Overall survival and subsequent therapy patterns in Japanese patients with ER+/HER2− advanced breast cancer treated with palbociclib plus letrozole in the first-line setting: a final analysis日本接受帕博西利+来曲唑一线治疗的ER+/HER2-晚期乳腺癌患者的总生存期及后续治疗模式：最终分析
errBreast Cancer
IF2.9
err2025-08-21
err0
errOAAI
errMasato Takahashi; Hiroyuki Yasojima; Tomofumi Osako; Kenichi Inoue; Masahiro Kawashima; Hideki Maeda; Mitsuya Ito; Yasuaki Sagara; Kan Yonemori; Masaya Hattori; Naohito Yamamoto; Yasuaki Muramatsu; Akiko Matsui; Norikazu Masuda
err分享
err收藏
Baseline risk variability by eligibility criteria in Cohort 1 of the monarchE trial for high-risk HR-positive, HER2-negative breast cancermonarchE试验中高风险HR阳性、HER2阴性乳腺癌队列1的基线风险变异性与纳入标准的关系
errBreast Cancer
IF2.9
err2025-07-28
err0
errOAAI
errMai Hoshino; Tatsunori Shimoi; Taro Yamanaka; Rui Kitadai; Munehiro Ito; Ayumi Saito; Shosuke Kita; Asuka Kawachi; Hitomi Sumiyoshi Okuma; Aiko Maejima; Yuki Kojima; Kazuki Sudo; Emi Noguchi; Yasuhiro Fujiwara; Jun Kato; Kan Yonemori
err分享
err收藏
Phase I study of H3B-6545 in patients with estrogen receptor-positive breast cancer☆H3B-6545在雌激素受体阳性乳腺癌患者中的I期研究☆
errESMO Open
IF8.3
err2025-06-01
err0
errOAAI
errK. Yonemori; T. Shimoi; K. Yamamoto; T. Kogawa; S. Kitano; S. Kobayashi; K. Yanai; K. Yamaguchi; Y. Otake; S. Hojo; M. Ono
err分享
err收藏
The prognostic factors and treatment patterns of the first recurrence of retroperitoneal liposarcoma腹膜后脂肪肉瘤首次复发的预后因素及治疗模式
errinternational journal of oncology
IF2.8
err2025-05-28
err0
PREAI
errMatsui, Yoshiyuki; Iwata, Shintaro; Moritani, Konosuke; Maejima, Aiko; Nara, Satoshi; Yamagata, Yukinori; Komiyama, Motokiyo; Kamio, Satoshi; Yonemori, Kan; Kawai, Akira; Fujimoto, Hiroyuki
err分享
err收藏
Nanomaterials-driven in situ vaccination: a novel frontier in tumor immunotherapy纳米材料驱动的原位疫苗接种：肿瘤免疫治疗的一个新前沿
errJOURNAL OF HEMATOLOGY & ONCOLOGY
IF40.4
err2025-04-17
err0
errOAAI
errLiu, Naimeng; Wang, Xiangyu; Wang, Zhongzhao; Kan, Yonemori; Fang, Yi; Gao, Jidong; Kong, Xiangyi
err分享
err收藏
Diagnosis and treatment of cardiac tumors心脏肿瘤的诊断与治疗
errMEDICAL ONCOLOGY
IF3.5
err2025-03-17
err0
errOAAI
errImai, Toru; Shimoi, Tatsunori; Kawai, Akira; Yonemori, Kan
err分享
err收藏
Clinical significance and efficacy of endoscopic ultrasound-guided tissue acquisition for para-aortic lymph node metastasis超声内镜引导下腹主动脉旁淋巴结转移组织采集的临床意义及疗效分析
errDIGESTIVE ENDOSCOPY
IF4.7
err2025-03-01
err0
errOAAI
errHara, Hidenobu; Hijioka, Susumu; Yamashige, Daiki; Nagashio, Yoshikuni; Komori, Yasuhiro; Kuwada, Masaru; Fukuda, Soma; Yagi, Shin; Okamoto, Kohei; Agarie, Daiki; Chatto, Mark; Okada, Mao; Maruki, Yuta; Morizane, Chigusa; Ueno, Hideki; Saito, Yutaka; Yonemori, Kan; Okusaka, Takuji
err分享
err收藏
HER2-negative or low expression as an unfavorable prognostic factor in patients with stage I/II uterine carcinosarcoma
errJOURNAL OF GYNECOLOGIC ONCOLOGY
IF3.7
err2025-01-01
err0
errOAAI
errMizoguchi, Chiharu; Nishikawa, Tadaaki; Yoshida, Hiroshi; Yasuda, Masanori; Kato, Tomoyasu; Hasegawa, Kosei; Yonemori, Kan
err分享
err收藏
Predictive modeling of oncogenic RNA expression using DNA alterations: Insights from Asian rare cancer patients基于DNA变异的致癌RNA表达预测建模：来自亚洲罕见癌症患者的见解
errANNALS OF ONCOLOGY
IF65.4
err2024-12-01
err0
PREAI
errde Almeida, K. Y.; Okuma, H. S.; Imasa, M. S.; Voon, P-j.; Fen, S. H. Hwoei; Chen, T. w-w.; Yusak, S.; Ramachandran, R.; Abu Bakar, N.; Chen, M-h.; Nakamura, K.; Yonemori, K.
err分享
err收藏
Clinical outcome of treatment rechallenge with HER2directed antibody-drug conjugate in metastatic breast cancer
errANNALS OF ONCOLOGY
IF65.4
err2024-10-01
err0
PREAI
errAndo, M. M.; Shimoi, T.; Imai, T.; Kojima, Y.; Sudo, K.; Yonemori, K.
err分享
err收藏
Correction: GLI1 confers resistance to PARP inhibitors by activating the DNA damage repair pathway
errONCOGENE
IF7.3
err2024-09-13
err0
PREAI
errIkeuchi, Hiroshi; Matsuno, Yusuke; Kusumoto-Matsuo, Rika; Kojima, Shinya; Ueno, Toshihide; Ikegami, Masachika; Kitada, Rina; Sumiyoshi-Okuma, Hitomi; Kojima, Yuki; Yonemori, Kan; Yatabe, Yasushi; Takamochi, Kazuya; Suzuki, Kenji; Yoshioka, Ken-ichi; Mano, Hiroyuki; Kohsaka, Shinji
err分享
err收藏
Real-world characterization of patients with advanced or metastatic dedifferentiated liposarcoma (DDLPS) in Japan in MASTER KEY projectMASTER KEY项目中日本晚期或转移性去分化脂肪肉瘤(DDLPS)患者的真实世界特征
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err0
PREAI
errTsuchihashi, K.; Okuma, H. S.; Baba, E.; Takahashi, M.; Kinoshita, I.; Muto, M.; Kamikura, M.; Sadachi, R.; Shibata, T.; Ichimura, M.; Sakamoto, W.; Hirata, Y.; Nakamura, K.; Yonemori, K.
err分享
err收藏
Genetic alteration in olfactory neuroblastoma: Unraveling carcinogenesis mechanisms and chemotherapy resistance through whole exome sequencing analysis嗅觉神经母细胞瘤中的遗传改变：通过全外显子组测序分析揭示致癌机制和化疗耐药性
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err0
PREAI
errFurukawa, H.; Shimoi, T.; Mori, T.; Honma, Y.; Noguchi, E.; Okuma, H. S.; Kojima, Y.; Yonemori, K.
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
P
Philippe Moreau
H 指数: 159 · 论文数: 2.3K
J
Jean‐Yves Blay
H 指数: 158 · 论文数: 2.4K
P
Patrick Y. Wen
H 指数: 145 · 论文数: 1.9K
C
Cristina R. Antonescu
H 指数: 142 · 论文数: 1.2K
H
Hope S. Rugo
H 指数: 137 · 论文数: 1.6K
查看更多